WO2008060368A3 - Transglutaminase-binding peptides and methods of use - Google Patents
Transglutaminase-binding peptides and methods of use Download PDFInfo
- Publication number
- WO2008060368A3 WO2008060368A3 PCT/US2007/021163 US2007021163W WO2008060368A3 WO 2008060368 A3 WO2008060368 A3 WO 2008060368A3 US 2007021163 W US2007021163 W US 2007021163W WO 2008060368 A3 WO2008060368 A3 WO 2008060368A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- transglutaminase
- binding peptides
- compositions
- subject matter
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The presently disclosed subject matter discloses diagnostic and prognostic techniques and compositions for the detection and evaluation of a pathologic disorder. Particularly, the presently disclosed subject matter relates to compositions and methods for evaluating the presence of transglutaminase expression in a pathologic condition compared to normal, healthy expression to diagnose, treat and effectively monitor the pathologic condition.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84871006P | 2006-10-02 | 2006-10-02 | |
US60/848,710 | 2006-10-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008060368A2 WO2008060368A2 (en) | 2008-05-22 |
WO2008060368A3 true WO2008060368A3 (en) | 2008-09-25 |
Family
ID=39402167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/021163 WO2008060368A2 (en) | 2006-10-02 | 2007-10-02 | Transglutaminase-binding peptides and methods of use |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008060368A2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060052308A1 (en) * | 2003-11-18 | 2006-03-09 | The Board Of Trustees Of The Leland Stanford Junior University | Transglutaminase inhibitors and methods of use thereof |
US20060083689A1 (en) * | 2001-01-05 | 2006-04-20 | Duke University | Contrast enhancement agent for magnetic resonance imaging |
US7049289B1 (en) * | 1998-05-15 | 2006-05-23 | Amersham Plc | Labelled glutamine and lysine analogues |
-
2007
- 2007-10-02 WO PCT/US2007/021163 patent/WO2008060368A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7049289B1 (en) * | 1998-05-15 | 2006-05-23 | Amersham Plc | Labelled glutamine and lysine analogues |
US20060083689A1 (en) * | 2001-01-05 | 2006-04-20 | Duke University | Contrast enhancement agent for magnetic resonance imaging |
US20060052308A1 (en) * | 2003-11-18 | 2006-03-09 | The Board Of Trustees Of The Leland Stanford Junior University | Transglutaminase inhibitors and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2008060368A2 (en) | 2008-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3070474A3 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
EP2813848A3 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
EP2767833A3 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
MX341191B (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure. | |
WO2008095492A3 (en) | A method for diagnosing atherosclerotic plaques by measurement of cd36 | |
NZ592358A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure using tissue inhibitor of metalloproteinase 2 (timp-2) | |
WO2007061906A3 (en) | Diagnostic and therapeutics for cardiovascular disorders | |
WO2008063527A8 (en) | Detection of deception and truth-telling using fmri of the brain | |
WO2007028162A3 (en) | Methods and compositions for identifying biomarkers useful in diagnosis and/or treatment of biological states | |
EP2811036A3 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
WO2008061149A3 (en) | Methods and compositions for diagnosis and prognosis of renal artery stenosis | |
WO2006042075A3 (en) | System and methods for assessing the neuromuscular pathway prior to nerve testing | |
WO2008073627A3 (en) | Method of diagnosing and treating asthma | |
EP3296406A3 (en) | Mirna fingerprint in the diagnosis of lung cancer | |
WO2010082944A3 (en) | Systems and methods for imaging changes in tissue | |
WO2011064225A8 (en) | Novel diagnostic method for the diagnosis of alzheimer's disease or mild cognitive impairment | |
MX336280B (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure. | |
WO2008009751A3 (en) | Transcription infidelity, detection and uses thereof | |
WO2010041046A3 (en) | Granin proteins as markers of heart disease | |
WO2007084397A3 (en) | Processing of slpi by chymase | |
WO2006124526A3 (en) | Method for assessing the effectiveness of a treatment regimen by determining zonulin | |
WO2010046648A3 (en) | Diagnostic test for streptococcus equi | |
WO2005116076A3 (en) | Neoplasm-specific polypeptides and their uses | |
WO2006085746A3 (en) | Diagnosis of metastases in hnscc tumours | |
WO2011084548A8 (en) | Methods and compositions for detecting recessive familial fsgs and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07861384 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07861384 Country of ref document: EP Kind code of ref document: A2 |